3C3 Stock Chart & Stats
€22.20
-€0.40(-2.20%)
At close: 4:00 PM EST
€22.20
-€0.40(-2.20%)
Day’s Range― - ―
52-Week Range€15.60 - €28.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€523.84M
Enterprise Value€678.91
Total Cash (Recent Filing)€84.61M
Total Debt (Recent Filing)€179.61M
Price to Earnings (P/E)23.5
Beta0.69
Next Earnings
Aug 19, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.06
Shares Outstanding24,048,925
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.66
Price to Book (P/B)0.84
Price to Sales (P/S)0.32
P/FCF Ratio3.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€26.28Price Target Upside18.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.22
Revenue Forecast (FY)€1.33B
Bulls Say, Bears Say
Bulls Say
De-risked Balance Sheet And Low LeverageA very low-debt, stable-equity profile gives Kimball sustained financial flexibility to fund medically oriented growth, absorb cyclical dips, and execute tuck-in M&A without forcing dilutive financing. Over 2–6 months this underpins strategic optionality and resilience.
Consistent Operating Cash Generation And Strong LiquidityRepeated positive operating cash flow and large available liquidity reduce refinancing and working-capacity risk while funding capex and M&A. This cash durability supports multi-quarter investment in facility ramps and the medical CMO build-out without material strain.
Strategic Medical CMO Expansion Via Helvoet AcquisitionThe Helvoet deal materially expands Kimball’s medical manufacturing capabilities, geographic footprint, and exposure to higher-growth, higher-margin healthcare end markets. This structural shift toward medical CMO services strengthens long-term revenue diversification and program stickiness.
Bears Say
Choppy Top-line And Recent Revenue SoftnessA pattern of uneven revenue (TTM decline and recent YoY drops) signals limited durable demand momentum and raises execution risk for margin recovery. Over 2–6 months, inconsistent bookings hinder predictable capacity utilization and constrain sustainable operating leverage.
Thin Margins And Known Ramp-related Margin DragMargins remain modest and face planned near-term pressure from a multi-year Indianapolis ramp. Ramp-related dual costs and delayed booking of capacity can compress gross margins for multiple quarters, challenging margin sustainability and free-cash-flow conversion until volumes scale.
Concentrated Exposure To Automotive With EV Demand ShiftsNearly half of revenue tied to automotive exposes Kimball to structural shifts in EV program timing and legislative-driven demand changes. Reduced awarded EV programs and lower steering-system demand create lasting revenue and book-to-bill uncertainty across planning cycles.
Kimball Electronics News
3C3 FAQ
What was Kimball Electronics Inc’s price range in the past 12 months?
Kimball Electronics Inc lowest stock price was €15.60 and its highest was €28.00 in the past 12 months.
What is Kimball Electronics Inc’s market cap?
Kimball Electronics Inc’s market cap is €523.84M.
When is Kimball Electronics Inc’s upcoming earnings report date?
Kimball Electronics Inc’s upcoming earnings report date is Aug 19, 2026 which is in 23 days.
How were Kimball Electronics Inc’s earnings last quarter?
Kimball Electronics Inc released its earnings results on May 05, 2026. The company reported €0.29 earnings per share for the quarter, missing the consensus estimate of €0.294 by -€0.004.
Is Kimball Electronics Inc overvalued?
According to Wall Street analysts Kimball Electronics Inc’s price is currently Undervalued.
Does Kimball Electronics Inc pay dividends?
Kimball Electronics Inc does not currently pay dividends.
What is Kimball Electronics Inc’s EPS estimate?
Kimball Electronics Inc’s EPS estimate is 0.34.
How many shares outstanding does Kimball Electronics Inc have?
Kimball Electronics Inc has 24,048,925 shares outstanding.
What happened to Kimball Electronics Inc’s price movement after its last earnings report?
Kimball Electronics Inc reported an EPS of €0.29 in its last earnings report, missing expectations of €0.294. Following the earnings report the stock price went down -5.263%.
Which hedge fund is a major shareholder of Kimball Electronics Inc?
Currently, no hedge funds are holding shares in DE:3C3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kimball Electronics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€26.28 (18.38% Upside)
€26.28 (18.38% Upside)
Blogger Sentiment
Bullish
DE:3C3 Sentiment 70%
Sector Average 64%
Sector Average 64%
Technicals
SMA
Negative
20 days / 200 days
Momentum
32.37%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.77%
Trailing 12-Months
Company Description
Kimball Electronics Inc
Kimball Electronics, Inc. specializes in providing comprehensive contract electronics manufacturing (CEM) and an array of diversified production solutions, catering to clients across the automotive, medical, industrial, and public safety sectors. Their extensive service portfolio encompasses initial design and development support, robust supply chain management, and agile rapid prototyping alongside streamlined product introduction capabilities. Key competencies also include comprehensive product design, rigorous process validation and qualification, and the industrialization and automation of complex manufacturing workflows. The company excels in reliability testing, subjecting products to a range of environmental conditions, and is proficient in the production and testing of printed circuit board assemblies. They also handle the assembly, production, and packaging of medical devices, including disposables and other non-electronic items, as well as electronic and non-electronic drug delivery systems. Additionally, their expertise extends to the design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics, complemented by software design services and holistic product life cycle management. With a significant global operational presence, Kimball Electronics conducts business in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Founded in 1961, the company maintains its headquarters in Jasper, Indiana.
3C3 Company Deck
3C3 Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a cautiously positive tone: the company reported sequential revenue growth, strong and accelerating Medical performance (now ~30% of revenue), margin improvement, continued positive operating cash flow, improved liquidity and affirmed full-year guidance. At the same time, management highlighted near-term pressures—reported YoY revenue decline (when unadjusted), soft Automotive and Industrial demand, margin headwinds from the Indianapolis ramp in FY'27, higher SG&A as a percent of sales, and macro/geopolitical risks. Strategic initiatives (Indianapolis facility, Medical CMO focus, active M&A pursuit) and solid balance sheet position offer upside, while the timing of CMO ramps and external demand trends represent meaningful near-term risks.View all DE:3C3 earnings summaries3C3 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€26.28
▲(18.38% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Espey Mfg & Electronics
―
Preformed Line Products Company
―
Ultralife
―
SKYX Platforms
―
AirJoule Technologies
―






